

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 8.73803352 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 8.73803352 |
| 3 | signal peptide processing (GO:0006465) | 5.93944921 |
| 4 | endocrine pancreas development (GO:0031018) | 5.78143575 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.65733588 |
| 6 | protein maturation by protein folding (GO:0022417) | 5.61782107 |
| 7 | COPII vesicle coating (GO:0048208) | 5.48476937 |
| 8 | peptide hormone processing (GO:0016486) | 5.29333814 |
| 9 | sequestering of metal ion (GO:0051238) | 5.24013762 |
| 10 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.09226317 |
| 11 | cell adhesion mediated by integrin (GO:0033627) | 4.95704529 |
| 12 | protein retention in ER lumen (GO:0006621) | 4.88141730 |
| 13 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.77064003 |
| 14 | hemidesmosome assembly (GO:0031581) | 4.64650442 |
| 15 | type B pancreatic cell development (GO:0003323) | 4.61223559 |
| 16 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.54252475 |
| 17 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.54093887 |
| 18 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.49336623 |
| 19 | ER overload response (GO:0006983) | 4.47015443 |
| 20 | desmosome organization (GO:0002934) | 4.46097081 |
| 21 | response to hepatocyte growth factor (GO:0035728) | 4.39813994 |
| 22 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.39813994 |
| 23 | cellular response to vitamin D (GO:0071305) | 4.37677079 |
| 24 | skin morphogenesis (GO:0043589) | 4.32239825 |
| 25 | positive regulation of nuclease activity (GO:0032075) | 4.26938847 |
| 26 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.11462203 |
| 27 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.00464865 |
| 28 | glandular epithelial cell differentiation (GO:0002067) | 3.98990367 |
| 29 | collagen fibril organization (GO:0030199) | 3.95510082 |
| 30 | chondrocyte proliferation (GO:0035988) | 3.95175839 |
| 31 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.89741107 |
| 32 | endodermal cell differentiation (GO:0035987) | 3.87885076 |
| 33 | vesicle coating (GO:0006901) | 3.87381055 |
| 34 | regulation of nuclease activity (GO:0032069) | 3.84728247 |
| 35 | glandular epithelial cell development (GO:0002068) | 3.83259598 |
| 36 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.78434634 |
| 37 | cellular response to unfolded protein (GO:0034620) | 3.78321355 |
| 38 | ER-nucleus signaling pathway (GO:0006984) | 3.66682262 |
| 39 | cellular response to topologically incorrect protein (GO:0035967) | 3.62709379 |
| 40 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.62072347 |
| 41 | exocrine pancreas development (GO:0031017) | 3.57462340 |
| 42 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.49648694 |
| 43 | magnesium ion transport (GO:0015693) | 3.46571753 |
| 44 | response to lipoprotein particle (GO:0055094) | 3.45772737 |
| 45 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.43336109 |
| 46 | cellular response to vitamin (GO:0071295) | 3.40394999 |
| 47 | peptidyl-asparagine modification (GO:0018196) | 3.39265510 |
| 48 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.38369855 |
| 49 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.34808350 |
| 50 | endothelial cell morphogenesis (GO:0001886) | 3.33869941 |
| 51 | cell-substrate junction assembly (GO:0007044) | 3.30161437 |
| 52 | protein heterotrimerization (GO:0070208) | 3.28336655 |
| 53 | fatty acid elongation (GO:0030497) | 3.26577485 |
| 54 | protein N-linked glycosylation (GO:0006487) | 3.26474670 |
| 55 | axon ensheathment in central nervous system (GO:0032291) | 3.24620598 |
| 56 | central nervous system myelination (GO:0022010) | 3.24620598 |
| 57 | positive regulation of insulin secretion (GO:0032024) | 3.22641688 |
| 58 | wound healing, spreading of epidermal cells (GO:0035313) | 3.22330578 |
| 59 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.21632594 |
| 60 | response to redox state (GO:0051775) | 3.20541231 |
| 61 | actin filament depolymerization (GO:0030042) | 3.20227784 |
| 62 | protein localization to endosome (GO:0036010) | 3.19379593 |
| 63 | response to endoplasmic reticulum stress (GO:0034976) | 3.18664788 |
| 64 | nucleotide transmembrane transport (GO:1901679) | 3.17122676 |
| 65 | insulin secretion (GO:0030073) | 3.16772446 |
| 66 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.15893415 |
| 67 | amyloid precursor protein catabolic process (GO:0042987) | 3.15651101 |
| 68 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.14576008 |
| 69 | epithelial cell-cell adhesion (GO:0090136) | 3.08639581 |
| 70 | kidney mesenchyme development (GO:0072074) | 3.08265152 |
| 71 | substrate-dependent cell migration (GO:0006929) | 3.07076325 |
| 72 | membrane protein ectodomain proteolysis (GO:0006509) | 3.05920580 |
| 73 | toxin metabolic process (GO:0009404) | 3.04793349 |
| 74 | astrocyte differentiation (GO:0048708) | 3.03932735 |
| 75 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.03196275 |
| 76 | type B pancreatic cell proliferation (GO:0044342) | 3.00326360 |
| 77 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.99344787 |
| 78 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.98574196 |
| 79 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.98574196 |
| 80 | cholesterol biosynthetic process (GO:0006695) | 2.98423531 |
| 81 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.98074675 |
| 82 | virion attachment to host cell (GO:0019062) | 2.97088847 |
| 83 | adhesion of symbiont to host cell (GO:0044650) | 2.97088847 |
| 84 | extracellular fibril organization (GO:0043206) | 2.96536157 |
| 85 | negative regulation of fatty acid transport (GO:2000192) | 2.95461684 |
| 86 | regulation of insulin secretion (GO:0050796) | 2.92625925 |
| 87 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.91861387 |
| 88 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.91284042 |
| 89 | response to unfolded protein (GO:0006986) | 2.90854697 |
| 90 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.90165958 |
| 91 | intestinal absorption (GO:0050892) | 2.88968551 |
| 92 | peptidyl-proline hydroxylation (GO:0019511) | 2.88442158 |
| 93 | 4-hydroxyproline metabolic process (GO:0019471) | 2.87867278 |
| 94 | barbed-end actin filament capping (GO:0051016) | 2.85865991 |
| 95 | paraxial mesoderm development (GO:0048339) | 2.83373321 |
| 96 | mesodermal cell differentiation (GO:0048333) | 2.83174309 |
| 97 | protein hydroxylation (GO:0018126) | 2.82734571 |
| 98 | cell migration involved in heart development (GO:0060973) | 2.81272605 |
| 99 | hippo signaling (GO:0035329) | 2.80948669 |
| 100 | Golgi organization (GO:0007030) | 2.80923235 |
| 101 | response to topologically incorrect protein (GO:0035966) | 2.80536855 |
| 102 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.80340504 |
| 103 | gap junction assembly (GO:0016264) | 2.79874206 |
| 104 | basement membrane organization (GO:0071711) | 2.79445025 |
| 105 | positive regulation of osteoblast proliferation (GO:0033690) | 2.79380750 |
| 106 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.79050547 |
| 107 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.78701638 |
| 108 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.78339930 |
| 109 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.78330148 |
| 110 | negative regulation of anoikis (GO:2000811) | 2.76708077 |
| 111 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.76676113 |
| 112 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.76099154 |
| 113 | muscle cell migration (GO:0014812) | 2.74193997 |
| 114 | collagen metabolic process (GO:0032963) | 2.73223202 |
| 115 | sphingosine metabolic process (GO:0006670) | 2.72463126 |
| 116 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.71939347 |
| 117 | extracellular matrix assembly (GO:0085029) | 2.71268487 |
| 118 | hypotonic response (GO:0006971) | 2.71234971 |
| 119 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.71170235 |
| 120 | peptide metabolic process (GO:0006518) | 2.71088931 |
| 121 | multicellular organismal metabolic process (GO:0044236) | 2.70818719 |
| 122 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.70771681 |
| 123 | gland morphogenesis (GO:0022612) | 2.70510267 |
| 124 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.69726612 |
| 125 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.69359356 |
| 126 | negative regulation of insulin secretion (GO:0046676) | 2.67393519 |
| 127 | eye photoreceptor cell differentiation (GO:0001754) | 2.65607065 |
| 128 | photoreceptor cell differentiation (GO:0046530) | 2.65607065 |
| 129 | midgut development (GO:0007494) | 2.65175807 |
| 130 | metanephric mesenchyme development (GO:0072075) | 2.65056554 |
| 131 | macroautophagy (GO:0016236) | 2.64964412 |
| 132 | regulation of peptide hormone secretion (GO:0090276) | 2.64594707 |
| 133 | membrane raft organization (GO:0031579) | 2.64163347 |
| 134 | smooth muscle tissue development (GO:0048745) | 2.62777296 |
| 135 | eosinophil chemotaxis (GO:0048245) | 2.62619878 |
| 136 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.62303210 |
| 137 | renal filtration (GO:0097205) | 2.62111607 |
| 138 | axon ensheathment (GO:0008366) | 2.61920540 |
| 139 | ensheathment of neurons (GO:0007272) | 2.61920540 |
| 140 | negative regulation of norepinephrine secretion (GO:0010700) | 2.61345976 |
| 141 | glycosylceramide metabolic process (GO:0006677) | 2.60528972 |
| 142 | regulation of peptide secretion (GO:0002791) | 2.59289629 |
| 143 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.59250370 |
| 144 | sterol biosynthetic process (GO:0016126) | 2.58829436 |
| 145 | Golgi vesicle transport (GO:0048193) | 2.58262014 |
| 146 | amyloid precursor protein metabolic process (GO:0042982) | 2.57918607 |
| 147 | extracellular matrix disassembly (GO:0022617) | 2.57809590 |
| 148 | wound healing, spreading of cells (GO:0044319) | 2.57516615 |
| 149 | protein localization to cell surface (GO:0034394) | 2.57012941 |
| 150 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.56533447 |
| 151 | myelination (GO:0042552) | 2.56275152 |
| 152 | regulation of metalloenzyme activity (GO:0048552) | 2.56053888 |
| 153 | nitric oxide mediated signal transduction (GO:0007263) | 2.56029251 |
| 154 | fibril organization (GO:0097435) | 2.55624176 |
| 155 | lymphangiogenesis (GO:0001946) | 2.55293417 |
| 156 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.55176871 |
| 157 | regulation of early endosome to late endosome transport (GO:2000641) | 2.54853668 |
| 158 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.53815989 |
| 159 | myelin maintenance (GO:0043217) | 2.53198039 |
| 160 | multicellular organismal catabolic process (GO:0044243) | 2.52889053 |
| 161 | negative regulation of stem cell proliferation (GO:2000647) | 2.52805053 |
| 162 | glomerular visceral epithelial cell development (GO:0072015) | 2.52490431 |
| 163 | regulation of plasminogen activation (GO:0010755) | 2.52382561 |
| 164 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.51913892 |
| 165 | hormone catabolic process (GO:0042447) | 2.51605042 |
| 166 | positive regulation of peptide hormone secretion (GO:0090277) | 2.49846332 |
| 167 | oligodendrocyte differentiation (GO:0048709) | 2.49439647 |
| 168 | glomerular basement membrane development (GO:0032836) | 2.48580003 |
| 169 | collagen catabolic process (GO:0030574) | 2.48449752 |
| 170 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.46910995 |
| 171 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.46345701 |
| 172 | regulation of extracellular matrix disassembly (GO:0010715) | 2.45906586 |
| 173 | creatine metabolic process (GO:0006600) | 2.45122532 |
| 174 | nucleoside diphosphate catabolic process (GO:0009134) | 2.43669326 |
| 175 | apoptotic cell clearance (GO:0043277) | 2.42988636 |
| 176 | regulation of chondrocyte differentiation (GO:0032330) | 2.42663196 |
| 177 | regulation of cardioblast differentiation (GO:0051890) | 2.42194079 |
| 178 | extracellular matrix organization (GO:0030198) | 2.40787210 |
| 179 | negative regulation of cartilage development (GO:0061037) | 2.40492535 |
| 180 | extracellular structure organization (GO:0043062) | 2.39842105 |
| 181 | adherens junction assembly (GO:0034333) | 2.39835572 |
| 182 | stress fiber assembly (GO:0043149) | 2.38509176 |
| 183 | axon extension involved in axon guidance (GO:0048846) | 2.38444863 |
| 184 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.38444863 |
| 185 | regulation of anoikis (GO:2000209) | 2.37427404 |
| 186 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.35416848 |
| 187 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.35145371 |
| 188 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.32791663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.76574485 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.54556790 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.17618478 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.70672679 |
| 5 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.50905358 |
| 6 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.47543966 |
| 7 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.47543966 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45637106 |
| 9 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.35566261 |
| 10 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.20953594 |
| 11 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.16117333 |
| 12 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.14699245 |
| 13 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.08928644 |
| 14 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.06495748 |
| 15 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.06495748 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05426583 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00631536 |
| 18 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.98880760 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94602137 |
| 20 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.93316813 |
| 21 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.91943635 |
| 22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.91424181 |
| 23 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.88874718 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86964508 |
| 25 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82483477 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.79842831 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74152565 |
| 28 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67604575 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62724874 |
| 30 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.61873375 |
| 31 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.61701372 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61562891 |
| 33 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.56176449 |
| 34 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.55367765 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55252319 |
| 36 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.53706507 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51594809 |
| 38 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.50322907 |
| 39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49217852 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48797909 |
| 41 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.45589895 |
| 42 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.45394210 |
| 43 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.45171018 |
| 44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44754257 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.44331563 |
| 46 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.43528580 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42479139 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42159101 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38820807 |
| 50 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.38179875 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37852706 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37221435 |
| 53 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36566938 |
| 54 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.33581976 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32080464 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31379893 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30546153 |
| 58 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.26817318 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.26325514 |
| 60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.25720722 |
| 61 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25135940 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24034787 |
| 63 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.22852184 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21239666 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21041782 |
| 66 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20704581 |
| 67 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20629676 |
| 68 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.18694940 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18367932 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17644486 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17567217 |
| 72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17207601 |
| 73 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16274548 |
| 74 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.15368670 |
| 75 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15336538 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.14126580 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13316795 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12779138 |
| 79 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12054667 |
| 80 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11787372 |
| 81 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10936428 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10898378 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10490739 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10340430 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08115540 |
| 86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07484828 |
| 87 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.07105199 |
| 88 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06582878 |
| 89 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.05822872 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05433610 |
| 91 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.05226536 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01967531 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01858034 |
| 94 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.01541044 |
| 95 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.01313004 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00701068 |
| 97 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00585825 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.00443438 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.00443438 |
| 100 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99329316 |
| 101 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99275470 |
| 102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99064687 |
| 103 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96915335 |
| 104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96894862 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95612912 |
| 106 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.94899174 |
| 107 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94519937 |
| 108 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94510661 |
| 109 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94334296 |
| 110 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.93614292 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93100530 |
| 112 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91069994 |
| 113 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.90230245 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89336513 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88926983 |
| 116 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88528565 |
| 117 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87058929 |
| 118 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87010857 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86780779 |
| 120 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.85924984 |
| 121 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85469362 |
| 122 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85090615 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85067692 |
| 124 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84758926 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84422026 |
| 126 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83874217 |
| 127 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83822870 |
| 128 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83133888 |
| 129 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82880348 |
| 130 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81819880 |
| 131 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81677951 |
| 132 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81426135 |
| 133 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81257704 |
| 134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81013573 |
| 135 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.79975567 |
| 136 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79737984 |
| 137 | GATA3_26560356_Chip-Seq_TH2_Human | 0.79343919 |
| 138 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77662030 |
| 139 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.76604639 |
| 140 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76491865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 5.21318289 |
| 2 | MP0004043_abnormal_pH_regulation | 4.33226531 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.01583610 |
| 4 | MP0003195_calcinosis | 3.98370013 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.80207072 |
| 6 | MP0003283_abnormal_digestive_organ | 3.71821627 |
| 7 | MP0002693_abnormal_pancreas_physiology | 3.23904785 |
| 8 | MP0000013_abnormal_adipose_tissue | 3.03838902 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.98954192 |
| 10 | MP0001944_abnormal_pancreas_morphology | 2.92647227 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.89666435 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.78264448 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.76053214 |
| 14 | MP0005623_abnormal_meninges_morphology | 2.66575671 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.59595837 |
| 16 | MP0005379_endocrine/exocrine_gland_phen | 2.51636975 |
| 17 | MP0003279_aneurysm | 2.47336520 |
| 18 | MP0006054_spinal_hemorrhage | 2.47295804 |
| 19 | MP0000462_abnormal_digestive_system | 2.44687625 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.42815553 |
| 21 | MP0000678_abnormal_parathyroid_gland | 2.39748745 |
| 22 | MP0003941_abnormal_skin_development | 2.37855876 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.36816413 |
| 24 | MP0005220_abnormal_exocrine_pancreas | 2.32987751 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.23907432 |
| 26 | MP0000920_abnormal_myelination | 2.10309744 |
| 27 | MP0005023_abnormal_wound_healing | 2.09592080 |
| 28 | MP0003091_abnormal_cell_migration | 1.91973072 |
| 29 | MP0002896_abnormal_bone_mineralization | 1.87548581 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.73016599 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.71896840 |
| 32 | MP0000003_abnormal_adipose_tissue | 1.70559759 |
| 33 | MP0002078_abnormal_glucose_homeostasis | 1.67063788 |
| 34 | MP0010030_abnormal_orbit_morphology | 1.66398110 |
| 35 | MP0001765_abnormal_ion_homeostasis | 1.62634486 |
| 36 | MP0005408_hypopigmentation | 1.58362489 |
| 37 | MP0005275_abnormal_skin_tensile | 1.57143718 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.56677614 |
| 39 | MP0000762_abnormal_tongue_morphology | 1.52347708 |
| 40 | MP0004264_abnormal_extraembryonic_tissu | 1.50329745 |
| 41 | MP0004272_abnormal_basement_membrane | 1.47936335 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.44024271 |
| 43 | MP0002295_abnormal_pulmonary_circulatio | 1.43907888 |
| 44 | MP0009053_abnormal_anal_canal | 1.43844952 |
| 45 | MP0003690_abnormal_glial_cell | 1.39335466 |
| 46 | MP0001879_abnormal_lymphatic_vessel | 1.39332051 |
| 47 | MP0005409_darkened_coat_color | 1.36161080 |
| 48 | MP0001542_abnormal_bone_strength | 1.35168851 |
| 49 | MP0003252_abnormal_bile_duct | 1.35051373 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.32478003 |
| 51 | MP0005310_abnormal_salivary_gland | 1.31077867 |
| 52 | MP0000613_abnormal_salivary_gland | 1.30789033 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.28420861 |
| 54 | MP0001661_extended_life_span | 1.27483826 |
| 55 | MP0000534_abnormal_ureter_morphology | 1.26288796 |
| 56 | MP0005501_abnormal_skin_physiology | 1.23999151 |
| 57 | MP0002928_abnormal_bile_duct | 1.21954883 |
| 58 | MP0000733_abnormal_muscle_development | 1.21606998 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.19144091 |
| 60 | MP0003634_abnormal_glial_cell | 1.17159100 |
| 61 | MP0004858_abnormal_nervous_system | 1.16718756 |
| 62 | MP0005197_abnormal_uvea_morphology | 1.15954204 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.15921937 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.14632178 |
| 65 | MP0004185_abnormal_adipocyte_glucose | 1.14519714 |
| 66 | MP0003868_abnormal_feces_composition | 1.14120672 |
| 67 | MP0009250_abnormal_appendicular_skeleto | 1.08573990 |
| 68 | MP0001756_abnormal_urination | 1.08552196 |
| 69 | MP0001849_ear_inflammation | 1.08552025 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.08295133 |
| 71 | MP0000467_abnormal_esophagus_morphology | 1.07254215 |
| 72 | MP0000751_myopathy | 1.05572405 |
| 73 | MP0005595_abnormal_vascular_smooth | 1.04963808 |
| 74 | MP0000537_abnormal_urethra_morphology | 1.04638530 |
| 75 | MP0004233_abnormal_muscle_weight | 1.04569016 |
| 76 | MP0003385_abnormal_body_wall | 1.04427925 |
| 77 | MP0000681_abnormal_thyroid_gland | 1.03799857 |
| 78 | MP0003329_amyloid_beta_deposits | 1.02319630 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.02277471 |
| 80 | MP0003795_abnormal_bone_structure | 1.01958413 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 1.01913499 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 1.01284290 |
| 83 | MP0003045_fibrosis | 1.00438705 |
| 84 | MP0005171_absent_coat_pigmentation | 0.99732878 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.98672255 |
| 86 | MP0000538_abnormal_urinary_bladder | 0.98359561 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.96827951 |
| 88 | MP0002108_abnormal_muscle_morphology | 0.96222026 |
| 89 | MP0006138_congestive_heart_failure | 0.94333973 |
| 90 | MP0002060_abnormal_skin_morphology | 0.91295913 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.90973355 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 0.88929476 |
| 93 | MP0003953_abnormal_hormone_level | 0.88418087 |
| 94 | MP0003755_abnormal_palate_morphology | 0.87852301 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.87269097 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.86934715 |
| 97 | MP0010678_abnormal_skin_adnexa | 0.86639708 |
| 98 | MP0005165_increased_susceptibility_to | 0.86501722 |
| 99 | MP0002168_other_aberrant_phenotype | 0.85411135 |
| 100 | MP0010771_integument_phenotype | 0.84734901 |
| 101 | MP0001958_emphysema | 0.84553519 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.83772965 |
| 103 | MP0009840_abnormal_foam_cell | 0.83490156 |
| 104 | MP0000428_abnormal_craniofacial_morphol | 0.82071441 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.81230151 |
| 106 | MP0000163_abnormal_cartilage_morphology | 0.81206368 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.81165864 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.80601388 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.80348695 |
| 110 | MP0003866_abnormal_defecation | 0.79023329 |
| 111 | MP0003959_abnormal_lean_body | 0.78186027 |
| 112 | MP0000432_abnormal_head_morphology | 0.77452073 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.77367939 |
| 114 | MP0001270_distended_abdomen | 0.77252570 |
| 115 | MP0005193_abnormal_anterior_eye | 0.77159635 |
| 116 | MP0004885_abnormal_endolymph | 0.75974265 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.75834204 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.75198625 |
| 119 | MP0005164_abnormal_response_to | 0.75112175 |
| 120 | MP0005535_abnormal_body_temperature | 0.74374603 |
| 121 | MP0000749_muscle_degeneration | 0.74254594 |
| 122 | MP0001915_intracranial_hemorrhage | 0.73607230 |
| 123 | MP0000639_abnormal_adrenal_gland | 0.71930712 |
| 124 | MP0005503_abnormal_tendon_morphology | 0.71859020 |
| 125 | MP0004084_abnormal_cardiac_muscle | 0.71621111 |
| 126 | MP0003942_abnormal_urinary_system | 0.71299198 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.70589214 |
| 128 | MP0005508_abnormal_skeleton_morphology | 0.69178584 |
| 129 | MP0003724_increased_susceptibility_to | 0.68765763 |
| 130 | MP0002796_impaired_skin_barrier | 0.68762667 |
| 131 | MP0001243_abnormal_dermal_layer | 0.68725784 |
| 132 | MP0001614_abnormal_blood_vessel | 0.68430285 |
| 133 | MP0005365_abnormal_bile_salt | 0.67815921 |
| 134 | MP0000579_abnormal_nail_morphology | 0.67409406 |
| 135 | MP0002933_joint_inflammation | 0.67176210 |
| 136 | MP0004947_skin_inflammation | 0.67032285 |
| 137 | MP0000627_abnormal_mammary_gland | 0.66638043 |
| 138 | MP0003950_abnormal_plasma_membrane | 0.66327755 |
| 139 | MP0000604_amyloidosis | 0.65513759 |
| 140 | MP0002128_abnormal_blood_circulation | 0.65022338 |
| 141 | MP0003935_abnormal_craniofacial_develop | 0.64712147 |
| 142 | MP0001485_abnormal_pinna_reflex | 0.63951749 |
| 143 | MP0001348_abnormal_lacrimal_gland | 0.62721407 |
| 144 | MP0009379_abnormal_foot_pigmentation | 0.62692824 |
| 145 | MP0002177_abnormal_outer_ear | 0.62599369 |
| 146 | MP0002697_abnormal_eye_size | 0.62247333 |
| 147 | MP0000759_abnormal_skeletal_muscle | 0.62183014 |
| 148 | MP0004134_abnormal_chest_morphology | 0.61089746 |
| 149 | MP0002090_abnormal_vision | 0.60546975 |
| 150 | MP0003448_altered_tumor_morphology | 0.60456443 |
| 151 | MP0000383_abnormal_hair_follicle | 0.59594342 |
| 152 | MP0005332_abnormal_amino_acid | 0.59524648 |
| 153 | MP0005646_abnormal_pituitary_gland | 0.58414224 |
| 154 | MP0002113_abnormal_skeleton_development | 0.57386925 |
| 155 | MP0003937_abnormal_limbs/digits/tail_de | 0.57187678 |
| 156 | MP0003828_pulmonary_edema | 0.56429744 |
| 157 | MP0002115_abnormal_skeleton_extremities | 0.55751694 |
| 158 | MP0005621_abnormal_cell_physiology | 0.55491671 |
| 159 | MP0005360_urolithiasis | 0.55270891 |
| 160 | MP0005390_skeleton_phenotype | 0.54998078 |
| 161 | MP0002876_abnormal_thyroid_physiology | 0.54394051 |
| 162 | MP0000647_abnormal_sebaceous_gland | 0.53892656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.37541611 |
| 2 | Protrusio acetabuli (HP:0003179) | 6.18594307 |
| 3 | Hypoglycemic seizures (HP:0002173) | 5.82316016 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.81117200 |
| 5 | Hypoglycemic coma (HP:0001325) | 5.63368376 |
| 6 | Symptomatic seizures (HP:0011145) | 5.62421564 |
| 7 | Aortic dissection (HP:0002647) | 4.56842268 |
| 8 | Vascular tortuosity (HP:0004948) | 4.44147734 |
| 9 | Arterial tortuosity (HP:0005116) | 4.26975854 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.16739658 |
| 11 | Mucopolysacchariduria (HP:0008155) | 4.16739658 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.14703952 |
| 13 | Aortic aneurysm (HP:0004942) | 4.14536777 |
| 14 | Generalized aminoaciduria (HP:0002909) | 4.08400437 |
| 15 | Atrophic scars (HP:0001075) | 4.02181628 |
| 16 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.86948628 |
| 17 | Large for gestational age (HP:0001520) | 3.83656293 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.79156790 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.79156790 |
| 20 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.79156790 |
| 21 | Ankle contracture (HP:0006466) | 3.76442111 |
| 22 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.72528055 |
| 23 | Hyperglycemia (HP:0003074) | 3.66129603 |
| 24 | Follicular hyperkeratosis (HP:0007502) | 3.57987963 |
| 25 | Ketoacidosis (HP:0001993) | 3.55775790 |
| 26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.47808055 |
| 27 | Osteolytic defects of the hand bones (HP:0009699) | 3.47808055 |
| 28 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.43158699 |
| 29 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.43158699 |
| 30 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.40500468 |
| 31 | Wormian bones (HP:0002645) | 3.35410582 |
| 32 | Vertebral compression fractures (HP:0002953) | 3.31606832 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 3.31062692 |
| 34 | Hypokalemia (HP:0002900) | 3.30462698 |
| 35 | Hyperparathyroidism (HP:0000843) | 3.28517744 |
| 36 | Soft skin (HP:0000977) | 3.25997577 |
| 37 | Fragile skin (HP:0001030) | 3.24166042 |
| 38 | Increased circulating renin level (HP:0000848) | 3.23520098 |
| 39 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.20500217 |
| 40 | Spinal rigidity (HP:0003306) | 3.19107502 |
| 41 | Bladder diverticulum (HP:0000015) | 3.14146327 |
| 42 | Hypokalemic alkalosis (HP:0001949) | 3.05566024 |
| 43 | Neurofibrillary tangles (HP:0002185) | 3.05560420 |
| 44 | Shallow orbits (HP:0000586) | 3.02146697 |
| 45 | Late onset (HP:0003584) | 3.00677144 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.99708305 |
| 47 | Abnormal pancreas size (HP:0012094) | 2.99656195 |
| 48 | Short nail (HP:0001799) | 2.97943841 |
| 49 | Abnormality of renin-angiotensin system (HP:0000847) | 2.90939979 |
| 50 | Abnormality of dentin (HP:0010299) | 2.89105353 |
| 51 | Neonatal short-limb short stature (HP:0008921) | 2.88935435 |
| 52 | Cardiovascular calcification (HP:0011915) | 2.84275992 |
| 53 | Thoracolumbar scoliosis (HP:0002944) | 2.80193073 |
| 54 | Decreased circulating renin level (HP:0003351) | 2.73252974 |
| 55 | Broad metatarsal (HP:0001783) | 2.72973544 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.72444918 |
| 57 | Mitral stenosis (HP:0001718) | 2.72366082 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.56873753 |
| 59 | Blue sclerae (HP:0000592) | 2.56845236 |
| 60 | Dilatation of the ascending aorta (HP:0005111) | 2.53414777 |
| 61 | Premature rupture of membranes (HP:0001788) | 2.52379197 |
| 62 | Hyperactive renin-angiotensin system (HP:0000841) | 2.52216780 |
| 63 | Hypomagnesemia (HP:0002917) | 2.50860176 |
| 64 | Mitral valve prolapse (HP:0001634) | 2.50253300 |
| 65 | Increased cerebral lipofuscin (HP:0011813) | 2.50245117 |
| 66 | Abnormality of potassium homeostasis (HP:0011042) | 2.47955706 |
| 67 | Metabolic alkalosis (HP:0200114) | 2.47498866 |
| 68 | Protuberant abdomen (HP:0001538) | 2.46073596 |
| 69 | Abnormality of chloride homeostasis (HP:0011422) | 2.45408402 |
| 70 | Abdominal distention (HP:0003270) | 2.44248481 |
| 71 | Elbow flexion contracture (HP:0002987) | 2.42116593 |
| 72 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.42034265 |
| 73 | Insulin resistance (HP:0000855) | 2.41172114 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.40431177 |
| 75 | Genu recurvatum (HP:0002816) | 2.39198923 |
| 76 | Exocrine pancreatic insufficiency (HP:0001738) | 2.37046789 |
| 77 | Progressive neurologic deterioration (HP:0002344) | 2.35961654 |
| 78 | Cerebral aneurysm (HP:0004944) | 2.34656222 |
| 79 | Glycosuria (HP:0003076) | 2.34176335 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 2.34176335 |
| 81 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33161128 |
| 82 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33161128 |
| 83 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33161128 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.31821767 |
| 85 | Abnormal protein glycosylation (HP:0012346) | 2.31057557 |
| 86 | Abnormal glycosylation (HP:0012345) | 2.31057557 |
| 87 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.31057557 |
| 88 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.31057557 |
| 89 | Hyperextensible skin (HP:0000974) | 2.30167467 |
| 90 | Thin bony cortex (HP:0002753) | 2.29870420 |
| 91 | Natal tooth (HP:0000695) | 2.27668277 |
| 92 | Hyperphosphaturia (HP:0003109) | 2.27496226 |
| 93 | Abnormality of magnesium homeostasis (HP:0004921) | 2.26658714 |
| 94 | Overgrowth (HP:0001548) | 2.26192493 |
| 95 | Hypophosphatemia (HP:0002148) | 2.25719090 |
| 96 | Ulnar bowing (HP:0003031) | 2.25409220 |
| 97 | Abnormality of the acetabulum (HP:0003170) | 2.23426517 |
| 98 | Mitral regurgitation (HP:0001653) | 2.23157209 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20843877 |
| 100 | Right ventricular cardiomyopathy (HP:0011663) | 2.20619145 |
| 101 | Coronal craniosynostosis (HP:0004440) | 2.20538771 |
| 102 | Hyperphosphatemia (HP:0002905) | 2.19355954 |
| 103 | Aortic regurgitation (HP:0001659) | 2.18970416 |
| 104 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.18308076 |
| 105 | Elevated alkaline phosphatase (HP:0003155) | 2.17095828 |
| 106 | Joint laxity (HP:0001388) | 2.16290946 |
| 107 | Retinal atrophy (HP:0001105) | 2.13686096 |
| 108 | Abnormality of the common coagulation pathway (HP:0010990) | 2.13421298 |
| 109 | Vascular calcification (HP:0004934) | 2.12923490 |
| 110 | Cerebral inclusion bodies (HP:0100314) | 2.11412654 |
| 111 | Osteomalacia (HP:0002749) | 2.07553018 |
| 112 | Abnormal urine phosphate concentration (HP:0012599) | 2.07088672 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 2.06958156 |
| 114 | Hydroxyprolinuria (HP:0003080) | 2.06958156 |
| 115 | Aneurysm (HP:0002617) | 2.06829864 |
| 116 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.05405795 |
| 117 | Wrist flexion contracture (HP:0001239) | 2.03022561 |
| 118 | Tetraparesis (HP:0002273) | 2.02497653 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.01913366 |
| 120 | Agitation (HP:0000713) | 2.01086736 |
| 121 | Alopecia of scalp (HP:0002293) | 2.00058083 |
| 122 | Ketosis (HP:0001946) | 1.98964321 |
| 123 | Delayed epiphyseal ossification (HP:0002663) | 1.98329832 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96733190 |
| 125 | Spinal cord lesions (HP:0100561) | 1.96484715 |
| 126 | Syringomyelia (HP:0003396) | 1.96484715 |
| 127 | Spinal cord compression (HP:0002176) | 1.96230436 |
| 128 | Tetany (HP:0001281) | 1.96020712 |
| 129 | Abnormal delivery (HP:0001787) | 1.95870316 |
| 130 | Cervical subluxation (HP:0003308) | 1.95306967 |
| 131 | Congenital glaucoma (HP:0001087) | 1.94829815 |
| 132 | Spondylolisthesis (HP:0003302) | 1.93250096 |
| 133 | Aortic valve stenosis (HP:0001650) | 1.92244934 |
| 134 | Abnormality of carpal bone ossification (HP:0006257) | 1.92127920 |
| 135 | Disproportionate short-trunk short stature (HP:0003521) | 1.91994902 |
| 136 | Pheochromocytoma (HP:0002666) | 1.91968265 |
| 137 | Absent frontal sinuses (HP:0002688) | 1.91597241 |
| 138 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91006706 |
| 139 | Pterygium (HP:0001059) | 1.89815467 |
| 140 | Knee flexion contracture (HP:0006380) | 1.89211045 |
| 141 | Increased connective tissue (HP:0009025) | 1.88280203 |
| 142 | Abnormality of purine metabolism (HP:0004352) | 1.87776514 |
| 143 | Hypoplasia of the iris (HP:0007676) | 1.86758241 |
| 144 | Bowel diverticulosis (HP:0005222) | 1.83601130 |
| 145 | Polydipsia (HP:0001959) | 1.83346449 |
| 146 | Abnormal drinking behavior (HP:0030082) | 1.83346449 |
| 147 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82713688 |
| 148 | Slender build (HP:0001533) | 1.80161391 |
| 149 | Abnormal ossification of hand bones (HP:0005921) | 1.78866492 |
| 150 | Unilateral renal agenesis (HP:0000122) | 1.78267845 |
| 151 | Wide anterior fontanel (HP:0000260) | 1.77960154 |
| 152 | Intrahepatic cholestasis (HP:0001406) | 1.77428424 |
| 153 | Metaphyseal irregularity (HP:0003025) | 1.76914036 |
| 154 | Polyuria (HP:0000103) | 1.75140959 |
| 155 | Broad face (HP:0000283) | 1.74776832 |
| 156 | Biconcave vertebral bodies (HP:0004586) | 1.74465370 |
| 157 | Tibial bowing (HP:0002982) | 1.74207949 |
| 158 | Upper limb amyotrophy (HP:0009129) | 1.74004777 |
| 159 | Distal upper limb amyotrophy (HP:0007149) | 1.74004777 |
| 160 | Irregular vertebral endplates (HP:0003301) | 1.72047359 |
| 161 | Papilledema (HP:0001085) | 1.71734937 |
| 162 | Coxa vara (HP:0002812) | 1.71477714 |
| 163 | Parakeratosis (HP:0001036) | 1.71422029 |
| 164 | Skin nodule (HP:0200036) | 1.70393397 |
| 165 | Enlarged epiphyses (HP:0010580) | 1.70181217 |
| 166 | Striae distensae (HP:0001065) | 1.69256796 |
| 167 | Delayed cranial suture closure (HP:0000270) | 1.69135959 |
| 168 | Camptodactyly of toe (HP:0001836) | 1.68787368 |
| 169 | Alkalosis (HP:0001948) | 1.68053777 |
| 170 | Breech presentation (HP:0001623) | 1.67498778 |
| 171 | Gout (HP:0001997) | 1.67421155 |
| 172 | Hyperaldosteronism (HP:0000859) | 1.67003678 |
| 173 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.66805910 |
| 174 | Villous atrophy (HP:0011473) | 1.66805910 |
| 175 | Abnormal urine output (HP:0012590) | 1.66769259 |
| 176 | Ectopia lentis (HP:0001083) | 1.66236459 |
| 177 | Anteriorly placed anus (HP:0001545) | 1.65086839 |
| 178 | Abnormality of the umbilical cord (HP:0010881) | 1.64987186 |
| 179 | Thin skin (HP:0000963) | 1.63175482 |
| 180 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.62524073 |
| 181 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62376091 |
| 182 | Disproportionate tall stature (HP:0001519) | 1.61862590 |
| 183 | Generalized amyotrophy (HP:0003700) | 1.59524666 |
| 184 | Peritonitis (HP:0002586) | 1.59017660 |
| 185 | Achilles tendon contracture (HP:0001771) | 1.58266107 |
| 186 | Onycholysis (HP:0001806) | 1.58246122 |
| 187 | Vertebral arch anomaly (HP:0008438) | 1.57739985 |
| 188 | Glucose intolerance (HP:0000833) | 1.57638067 |
| 189 | Round ear (HP:0100830) | 1.56901926 |
| 190 | Hallux valgus (HP:0001822) | 1.56748726 |
| 191 | Selective tooth agenesis (HP:0001592) | 1.56637407 |
| 192 | Deviation of the hallux (HP:0010051) | 1.56325594 |
| 193 | Protruding ear (HP:0000411) | 1.54785515 |
| 194 | Femoral bowing (HP:0002980) | 1.54619910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.80052503 |
| 2 | PASK | 3.86405446 |
| 3 | WNK4 | 3.25677707 |
| 4 | MYLK | 3.19715215 |
| 5 | TAOK3 | 3.15820696 |
| 6 | STK39 | 2.97482171 |
| 7 | EPHB1 | 2.92465871 |
| 8 | EPHA2 | 2.83539235 |
| 9 | MET | 2.64960818 |
| 10 | MAP3K2 | 2.60373376 |
| 11 | LMTK2 | 2.59345809 |
| 12 | ERN1 | 2.56315863 |
| 13 | FRK | 2.46608623 |
| 14 | IRAK3 | 2.42248590 |
| 15 | NEK9 | 2.38828933 |
| 16 | HIPK2 | 2.38334954 |
| 17 | MAPK15 | 2.38096194 |
| 18 | LATS2 | 2.36421138 |
| 19 | PAK4 | 2.25606429 |
| 20 | IRAK1 | 2.20092884 |
| 21 | EPHB2 | 2.19186048 |
| 22 | TTN | 2.19084830 |
| 23 | OXSR1 | 2.12972691 |
| 24 | TGFBR2 | 2.00316999 |
| 25 | NTRK1 | 1.90096074 |
| 26 | PRKD3 | 1.88502799 |
| 27 | MAP3K12 | 1.79974013 |
| 28 | RIPK1 | 1.78149363 |
| 29 | MST4 | 1.73144080 |
| 30 | BCR | 1.70690065 |
| 31 | PTK2 | 1.63484562 |
| 32 | EPHA3 | 1.63365817 |
| 33 | PDGFRA | 1.61372724 |
| 34 | IRAK2 | 1.60130839 |
| 35 | PBK | 1.58406519 |
| 36 | SCYL2 | 1.53825002 |
| 37 | IRAK4 | 1.50727965 |
| 38 | PTK6 | 1.46348538 |
| 39 | MAP3K1 | 1.38259980 |
| 40 | MOS | 1.37415435 |
| 41 | STK38L | 1.37135791 |
| 42 | STK24 | 1.36239818 |
| 43 | EIF2AK3 | 1.35560461 |
| 44 | FLT3 | 1.34434979 |
| 45 | LIMK1 | 1.30398847 |
| 46 | TESK1 | 1.28770400 |
| 47 | ERBB3 | 1.24212118 |
| 48 | PAK3 | 1.24048532 |
| 49 | TRIB3 | 1.21315453 |
| 50 | UHMK1 | 1.19755742 |
| 51 | WNK1 | 1.19709613 |
| 52 | NEK1 | 1.16154750 |
| 53 | STK38 | 1.09311252 |
| 54 | PRKG2 | 1.07886801 |
| 55 | CAMKK2 | 1.07128779 |
| 56 | TIE1 | 1.03964134 |
| 57 | LATS1 | 1.03946763 |
| 58 | ILK | 1.02813820 |
| 59 | TNIK | 1.01222508 |
| 60 | MST1R | 1.00960881 |
| 61 | CDC42BPA | 0.91744754 |
| 62 | ICK | 0.91244177 |
| 63 | NEK6 | 0.91036453 |
| 64 | SIK1 | 0.88905635 |
| 65 | AKT3 | 0.88018922 |
| 66 | BRSK2 | 0.87113132 |
| 67 | FER | 0.84683186 |
| 68 | ROCK2 | 0.84528468 |
| 69 | WNK3 | 0.84030314 |
| 70 | PDK2 | 0.83655072 |
| 71 | MAPKAPK5 | 0.83511044 |
| 72 | EIF2AK1 | 0.83469051 |
| 73 | PDGFRB | 0.83358070 |
| 74 | MAP2K2 | 0.80083859 |
| 75 | MAP3K3 | 0.79992984 |
| 76 | CAMK2D | 0.79192944 |
| 77 | MELK | 0.78826279 |
| 78 | PRKCH | 0.76416959 |
| 79 | TGFBR1 | 0.75035713 |
| 80 | DYRK1B | 0.73220934 |
| 81 | CDK8 | 0.72887368 |
| 82 | BMPR1B | 0.71120670 |
| 83 | CSNK1A1L | 0.70941526 |
| 84 | GSK3A | 0.70528142 |
| 85 | PRKD1 | 0.69705111 |
| 86 | KSR1 | 0.68339285 |
| 87 | PIK3CG | 0.68092149 |
| 88 | MTOR | 0.66759463 |
| 89 | MAP3K6 | 0.66071479 |
| 90 | JAK2 | 0.66055929 |
| 91 | ITK | 0.64697318 |
| 92 | DDR2 | 0.63400146 |
| 93 | JAK3 | 0.63148292 |
| 94 | TTK | 0.62358950 |
| 95 | JAK1 | 0.60348718 |
| 96 | ERBB4 | 0.60044927 |
| 97 | EEF2K | 0.60041443 |
| 98 | ARAF | 0.58910036 |
| 99 | DMPK | 0.58009432 |
| 100 | FGFR2 | 0.57764801 |
| 101 | NUAK1 | 0.56688814 |
| 102 | RET | 0.54611384 |
| 103 | NLK | 0.54404166 |
| 104 | CDK6 | 0.54050792 |
| 105 | PRKD2 | 0.53170416 |
| 106 | PAK6 | 0.52910805 |
| 107 | FGFR1 | 0.52456117 |
| 108 | TRIM28 | 0.49110231 |
| 109 | ABL2 | 0.48869112 |
| 110 | MAPKAPK3 | 0.48589829 |
| 111 | PIM2 | 0.46785488 |
| 112 | PDPK1 | 0.46527083 |
| 113 | CSK | 0.46269079 |
| 114 | WEE1 | 0.45785468 |
| 115 | CAMK2B | 0.44531643 |
| 116 | MAP2K1 | 0.43432307 |
| 117 | CSNK1G1 | 0.42958165 |
| 118 | PTK2B | 0.42627242 |
| 119 | AKT2 | 0.41846878 |
| 120 | TRPM7 | 0.41414113 |
| 121 | IGF1R | 0.41211843 |
| 122 | DAPK3 | 0.40872399 |
| 123 | CSNK1G3 | 0.40633053 |
| 124 | MAP3K8 | 0.39879734 |
| 125 | BRSK1 | 0.39639404 |
| 126 | PIK3CA | 0.38847068 |
| 127 | PAK2 | 0.37955506 |
| 128 | CAMK2G | 0.37675942 |
| 129 | BUB1 | 0.36973349 |
| 130 | LRRK2 | 0.36672148 |
| 131 | STK10 | 0.36342337 |
| 132 | PKN1 | 0.35060708 |
| 133 | ACVR1B | 0.34627813 |
| 134 | BMX | 0.34480218 |
| 135 | CSNK1A1 | 0.34313960 |
| 136 | PKN2 | 0.33748612 |
| 137 | NME2 | 0.33600000 |
| 138 | CDK9 | 0.32047400 |
| 139 | FGFR4 | 0.31980959 |
| 140 | RPS6KA2 | 0.31648136 |
| 141 | KSR2 | 0.31150780 |
| 142 | PAK1 | 0.30895876 |
| 143 | CSNK1G2 | 0.30548732 |
| 144 | PLK2 | 0.30060317 |
| 145 | ADRBK1 | 0.29469737 |
| 146 | TBK1 | 0.29360597 |
| 147 | SGK223 | 0.29255396 |
| 148 | SGK494 | 0.29255396 |
| 149 | ROCK1 | 0.28837420 |
| 150 | PRKCQ | 0.28658753 |
| 151 | STK3 | 0.28266903 |
| 152 | * PRKCE | 0.28061475 |
| 153 | INSR | 0.27840403 |
| 154 | AURKB | 0.27521699 |
| 155 | BCKDK | 0.26590660 |
| 156 | ABL1 | 0.25446010 |
| 157 | TEC | 0.25217195 |
| 158 | FGFR3 | 0.25179400 |
| 159 | PRKACG | 0.21235411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.22098805 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.64332500 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.69309646 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.00946494 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.40818823 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.39519452 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.15757662 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.06927487 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.02581851 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.94445965 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.77318114 |
| 12 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.67594778 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67556177 |
| 14 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.66637100 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.64458107 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.62670026 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55265536 |
| 18 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.55253580 |
| 19 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.54790389 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.53571197 |
| 21 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.42514611 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.40314214 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.38150389 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.36366897 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35196506 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.33648929 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32360718 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32281442 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30398221 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28107841 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25578884 |
| 32 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.24904771 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.22005033 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.21004183 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.20390095 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17997018 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.12099572 |
| 38 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.09889320 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08363549 |
| 40 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05686988 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03683355 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01852828 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00510831 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.99098800 |
| 45 | Melanoma_Homo sapiens_hsa05218 | 0.98794433 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97957116 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93553479 |
| 48 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93200018 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90372958 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90240423 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89188431 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87286685 |
| 53 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.87113268 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 0.87077646 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86960405 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.86585757 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85886679 |
| 58 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.85427439 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.85057701 |
| 60 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.84111762 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84092824 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81422364 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80672701 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80042270 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79888245 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79104116 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77359230 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.76914185 |
| 69 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.75403296 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.74643766 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73653888 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73454963 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.71833519 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 0.71212276 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71163760 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69551577 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.69062537 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.68815029 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.68800968 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 0.68695165 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68112987 |
| 82 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67635389 |
| 83 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66439111 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.65845381 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63455109 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63140963 |
| 87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62862624 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62620211 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62590772 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.61715704 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60264348 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59920287 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.58905792 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57453705 |
| 95 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57371217 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55904119 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55688542 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55064461 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53560363 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52467928 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51521565 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51412451 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51171582 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47653944 |
| 105 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47542543 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45342222 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.45284481 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44912194 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.44843380 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44746387 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.44650709 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44596614 |
| 113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44466546 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43630707 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42958473 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42594614 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41326041 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41225237 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.39687843 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.38113897 |
| 121 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37269084 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36978039 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35593589 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.34028985 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33447184 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.33393861 |
| 127 | Legionellosis_Homo sapiens_hsa05134 | 0.33346295 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32849186 |
| 129 | Malaria_Homo sapiens_hsa05144 | 0.31654303 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31468512 |
| 131 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30510343 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | 0.30402140 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29836824 |
| 134 | Tight junction_Homo sapiens_hsa04530 | 0.29283009 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26582020 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25920807 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.25352676 |
| 138 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23370215 |
| 139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20879317 |
| 140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20683064 |
| 141 | Tuberculosis_Homo sapiens_hsa05152 | 0.20294657 |
| 142 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.20001948 |
| 143 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.19222479 |
| 144 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.18635363 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16471603 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16454621 |
| 147 | Adherens junction_Homo sapiens_hsa04520 | 0.16377971 |
| 148 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.13879217 |
| 149 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.13322410 |
| 150 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.12611741 |

